About Intact Vascular
Intact Vascular is a Healthcare company based in Wayne (United States) founded in 2011, and was acquired by Philips in August 2020. Implants for repairing arteries after angioplasty are developed. Intact Vascular has raised $123.4 million across 10 funding rounds from investors including Philips, Runway Growth Capital and Vensana Capital. The company was acqui-hired. Intact Vascular offers products and services including Vascular Suite, Azurion 7 M20, and Sonicare Toothbrush. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is INTACT VASCULAR, INC. Its competitors include Avinger, LeMaitre Vascular and Okami Medical; 3 of its 3 listed competitors have raised funding.
Company details
Intact Vascular was founded in 2011 as a privately held medical device company located in Wayne, United States. Minimally invasive peripheral vascular products are developed by the company to address peripheral artery disease. The Tack Endovascular System, a metal implant, is utilized to repair arterial dissections that occur following angioplasty procedures. Approval has been granted by the FDA, and the CE mark has been received for the device.
Products & Services of Intact Vascular
Intact Vascular offers a comprehensive portfolio of products and services, including Vascular Suite, Azurion 7 M20, and Sonicare Toothbrush.
Supports vascular procedures with real-time guidance and imaging tools.
Ceiling-mounted system for flexible peripheral and aneurysm procedures.
Electric toothbrush for improved oral health and cleaning.
Apps and channels of Intact Vascular
its YouTube channel Signify has 1.44K subscribers and 30 videos.
Videos from Intact Vascular
The most watched videos on Intact Vascular's YouTube channel, Signify (1.44K subscribers). Click a video to play it here.
More on Signify.
Funding Insights of Intact Vascular
Intact Vascular has successfully raised a total of $123.4M across 10 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $30 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $123.4M
- Total Rounds 10
- Last Round Debt – Venture — $30M
- First Round $1.12M
(Jan 2012)
- Investors Count 5
All 10 funding rounds of Intact Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $30M | Debt – Venture | – | – | |
| May 2020 | $13.5M | Series D | – | – | – |
| May 2019 | $25M | Series D | – | Vensana Capital | |
| Apr 2018 | $20M | Series C | – | HIG BioHealth Partners | |
| Jan 2017 | $39.34M | Series B | – | New Enterprise Associates | |
| Mar 2015 | $3.01M | Series A | – | – | – |
| Dec 2013 | $4.69M | Series A | – | – | – |
| Aug 2012 | $15.5M | Series A | – | HIG BioHealth Partners, Quaker Partners Management | – |
| Feb 2012 | $1.25M | Series A | – | – | – |
| Jan 2012 | $1.12M | Seed | – | – | – |
6 investors in total: 6 institutional.
Investors in Intact Vascular
Intact Vascular has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Philips, Runway Growth Capital and Vensana Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in medical technology are made by Vensana Capital. | vensanacap.com | Minneapolis, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
| quakerpartners.com | ||||
Venture debt financing is provided to companies across multiple sectors. | 2015 | runwaygrowth.com | Woodside, United States | |
| higbio.com | ||||
Diversified products are provided across health, lighting, and consumer sectors. | 1891 | philips.com | Amsterdam, Netherlands |
Investor details for Intact Vascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Intact Vascular
4 dated milestones of Intact Vascular across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Intact Vascular is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Debt – Venture, of $30.0M.
- Exit Acquired by Philips.
Competitors of Intact Vascular
Intact Vascular has 3 listed competitors in our database, 3 of them funded. They include Avinger, LeMaitre Vascular and Okami Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avinger.com | 2007 | Redwood, United States | $170.85M | 80 | Provider of image-guided catheter-based products for peripheral artery disease | |
| lemaitre.com | 1983 | Burlington, United States | $4.38M | 317 | Devices for peripheral vascular disease treatment are developed and marketed. | |
| okamimedical.com | 2011 | Aliso Viejo, United States | $62.09M | Innovative medical devices for peripheral vessel treatment are developed. |
Detailed competitors of Intact Vascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Intact Vascular (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Intact Vascular
Complete news archive for Intact Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intact Vascular
Intact Vascular was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Intact Vascular is headquartered in Wayne, United States.
Intact Vascular is a funded company, having raised a total of $123.4M across 10 funding rounds to date. The company's 1st funding round was a Seed of $1.12M, raised on Jan 2012.
Intact Vascular was founded in 2011 as a privately held medical device company located in Wayne, United States. Minimally invasive peripheral vascular products are developed by the company to address peripheral artery disease. The Tack Endovascular System, a metal implant, is utilized to repair arterial dissections that occur following angioplasty procedures. Approval has been granted by the FDA, and the CE mark has been received for the device.
Intact Vascular's top competitors include Avinger, Okami Medical and LeMaitre Vascular.
Intact Vascular offers Vascular Suite, Azurion 7 M20, and Sonicare Toothbrush.
Intact Vascular has 6 investors. Key investors include Philips, Runway Growth Capital, Vensana Capital, NEA, and HIG BioHealth Partners.
Intact Vascular operates through Intact Vascular, Inc..
Yes. Intact Vascular was acquired by Philips in August 2020.